1
|
Doran C, Duits A, Tami A, Gerstenbluth I, Bailey A. "It's very saddening, you keep on wondering when the symptoms will be over": A qualitative study exploring the long-term chikungunya disease impact on daily life and well-being, 6 years after disease onset. PLoS Negl Trop Dis 2023; 17:e0011793. [PMID: 38055664 DOI: 10.1371/journal.pntd.0011793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2023] [Accepted: 11/14/2023] [Indexed: 12/08/2023] Open
Abstract
BACKGROUND Long-term chikungunya is a mosquito-borne disease, characterized by disabling rheumatic symptoms persisting for years, after infection with the chikungunya virus. Previous studies focused on assessing the well-being of affected individuals from a quantitative perspective using generic instruments, and have reported physical and psychological impairment. However, a common critique is that generic instrument's structured responses and pre-defined health domains selected by health professionals, may not capture the full extent of well-being impairment experienced by patients. This study aimed to explore in-depth to which extent long-term chikungunya disease impacts daily living and the physical, psychological, and social well-being from the experiences and perspective of affected individuals. METHODOLOGY/PRINCIPAL FINDINGS Using open-ended questions, in-depth interviews were conducted with 20 purposively selected individuals with long-term chikungunya disease, in Curaçao. Interview audio-recordings were transcribed verbatim. The data were thematically analyzed. Living with persistent rheumatic symptoms affected the participant's daily living and well-being in several ways: experience of physical impact (restricted physical functioning and limitations in activities of daily life); experience of psychological impact (altered emotional state, fear of walking and running, psychosocial aspects of footwear adaptations, and uncertainty about disease progression and future health); and experience of social impact (social isolation and impaired relational maintenance, social dependency, challenges of social support, at-work productivity loss, and giving up leisure activities after work). CONCLUSIONS/SIGNIFICANCE This study, the first of its kind, indicated that the adverse impact of long-term chikungunya disease is currently underreported. The persistent rheumatic symptoms had a negative effect on functional ability, which in turn impacted broad aspects of daily life and well-being, beyond what is captured by generic instruments. In the view of the findings, physical exercise programs including manual therapy, aerobics, resistance and stretching exercises, and orthopaedic footwear interventions in a multidisciplinary patient-centred approach may improve physical function and subsequently overall well-being.
Collapse
Affiliation(s)
- Churnalisa Doran
- University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands
- Curaçao Biomedical and Health Research Institute, Willemstad, Curaçao
| | - Ashley Duits
- Red Cross Blood Bank Foundation, Willemstad, Curaçao
- Department of Immunology, Curaçao Biomedical and Health Research Institute, Willemstad, Curaçao
- Institute for Medical Education, University Medical Center Groningen, Groningen, The Netherlands
| | - Adriana Tami
- University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands
| | - Izzy Gerstenbluth
- Department of Epidemiology, Curaçao Biomedical and Health Research Institute, Willemstad, Curaçao
| | - Ajay Bailey
- Department of Human Geography and Spatial Planning, University of Utrecht, Utrecht, The Netherlands
| |
Collapse
|
2
|
Doran C, Gerstenbluth I, Duits A, Lourents N, Halabi Y, Burgerhof J, Tami A, Bailey A. The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospective cohort study in Curaçao. BMC Infect Dis 2022; 22:948. [PMID: 36526964 PMCID: PMC9756924 DOI: 10.1186/s12879-022-07922-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Accepted: 12/06/2022] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND Persistent rheumatic symptoms and its impact on health-related quality of life (QoL), induced by the Indian Ocean Lineage (IOL) chikungunya virus (CHIKV) genotype have been widely studied. In 2014, a major CHIKV outbreak of the Asian genotype occurred in Curaçao, after which we established a longitudinal cohort in 2015, to follow the long-term CHIKV sequalae. Currently, the long-term clinical manifestations and its impact on QoL induced by the Asian CHIKV genotype, followed prospectively through time, and the association of age and comorbidities with rheumatic symptoms persistence, 60 months (M60) after disease onset is unknown. METHODS The cohort of 304 laboratory confirmed patients were followed prospectively in time at 3-16 months (M3-16), 30 months (M30), and M60 after disease onset. Demographic and clinical characteristics, and the 36-item short-form survey (SF-36) QoL status were collected through questionnaires. At M60, QoL scores were compared to general population (CHIK-) norms. RESULTS A total of 169 (56%) patients participated (74.6% female, mean age 56.1 years) at all time points, 107 (63%) were classified as recovered and 62 (37%) as affected. The affected patients reported an increase in the prevalence of arthralgia (P .001) and arthralgia in the lower extremities (P < .001), at M30 compared to M3-16. At M60, in comparison to recovered patients, affected patients reported a higher prevalence of recurrent rheumatic symptoms of moderate to severe pain, irrespective of age and comorbidities, and a higher prevalence of non-rheumatic symptoms (P < .001). Arthralgia in the upper (odds ratio (OR): 4.79; confidence interval (CI): 2.01-11.44; P < .001) and lower (OR: 8.68; CI: 3.47-21.69; P < .001) extremities, and headache (OR: 3.85; CI: 1.40-10.54; P = .009) were associated with being affected. The SF-36 QoL scores of the recovered patients were less impaired over time compared to the QoL scores of the affected patients. At M60, the QoL scores of the recovered patients were comparable to the CHIK- QoL scores. CONCLUSIONS Rheumatic and non-rheumatic symptoms, and QoL impairment may persist, 60 months following infection with the Asian CHIKV genotype, similar to the IOL genotype disease sequelae. Further research is needed to follow the clinical manifestations and QoL impact of each CHIKV genotype.
Collapse
Affiliation(s)
- Churnalisa Doran
- grid.4494.d0000 0000 9558 4598Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
| | - Izzy Gerstenbluth
- Curaçao Biomedical and Health Research Institute, Pater Eeuwensweg 36, Willemstad, Curaçao
| | - Ashley Duits
- Curaçao Biomedical and Health Research Institute, Pater Eeuwensweg 36, Willemstad, Curaçao
| | - Norediz Lourents
- Epidemiology and Research Unit, Medical and Public Health Service Curaçao, Piscaderaweg 49, Willemstad, Curaçao
| | - Yaskara Halabi
- Epidemiology and Research Unit, Medical and Public Health Service Curaçao, Piscaderaweg 49, Willemstad, Curaçao
| | - Johannes Burgerhof
- grid.4494.d0000 0000 9558 4598Department of Epidemiology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
| | - Adriana Tami
- grid.4494.d0000 0000 9558 4598Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
| | - Ajay Bailey
- grid.5477.10000000120346234Department of Human Geography and Spatial Planning, University of Utrecht, Heidelberglaan 8, 3584 CS Utrecht, The Netherlands
| |
Collapse
|
3
|
Khongwichit S, Chansaenroj J, Chirathaworn C, Poovorawan Y. Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries. J Biomed Sci 2021; 28:84. [PMID: 34857000 PMCID: PMC8638460 DOI: 10.1186/s12929-021-00778-8] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Accepted: 11/21/2021] [Indexed: 02/03/2023] Open
Abstract
Chikungunya virus (CHIKV) is a re-emerging mosquito-borne human pathogen that causes chikungunya fever, which is typically accompanied by severe joint pain. In Asia, serological evidence indicated that CHIKV first emerged in 1954. From the 1950’s to 2005, sporadic CHIKV infections were attributed to the Asian genotype. However, the massive outbreak of CHIKV in India and the Southwest Indian Ocean Islands in 2005 has since raised chikungunya as a worldwide public health concern. The virus is spreading globally, but mostly in tropical and subtropical regions, particularly in South and Southeast Asia. The emergence of the CHIKV East/Central/South African genotype-Indian Ocean lineage (ECSA-IOL) has caused large outbreaks in South and Southeast Asia affected more than a million people over a decade. Notably, the massive CHIKV outbreaks before 2016 and the more recent outbreak in Asia were driven by distinct ECSA lineages. The first significant CHIKV ECSA strains harbored the Aedes albopictus-adaptive mutation E1: A226V. More recently, another mass CHIKV ECSA outbreak in Asia started in India and spread beyond South and Southeast Asia to Kenya and Italy. This virus lacked the E1: A226V mutation but instead harbored two novel mutations (E1: K211E and E2: V264A) in an E1: 226A background, which enhanced its fitness in Aedes aegypti. The emergence of a novel ECSA strain may lead to a more widespread geographical distribution of CHIKV in the future. This review summarizes the current CHIKV situation in Asian countries and provides a general overview of the molecular virology, disease manifestation, diagnosis, prevalence, genotype distribution, evolutionary relationships, and epidemiology of CHIKV infection in Asian countries over the past 65 years. This knowledge is essential in guiding the epidemiological study, control, prevention of future CHIKV outbreaks, and the development of new vaccines and antivirals targeting CHIKV.
Collapse
Affiliation(s)
- Sarawut Khongwichit
- Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand
| | - Jira Chansaenroj
- Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand
| | - Chintana Chirathaworn
- Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.,Tropical Medicine Cluster, Chulalongkorn University, Bangkok, 10330, Thailand
| | - Yong Poovorawan
- Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
| |
Collapse
|
4
|
Tjaden NB, Cheng Y, Beierkuhnlein C, Thomas SM. Chikungunya Beyond the Tropics: Where and When Do We Expect Disease Transmission in Europe? Viruses 2021; 13:v13061024. [PMID: 34072346 PMCID: PMC8226708 DOI: 10.3390/v13061024] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Revised: 05/24/2021] [Accepted: 05/25/2021] [Indexed: 02/02/2023] Open
Abstract
Chikungunya virus disease (chikungunya) is a mosquito-borne infectious disease reported in at least 50 countries, mostly in the tropics. It has spread around the globe within the last two decades, with local outbreaks in Europe. The vector mosquito Aedes albopictus (Diptera, Culicidae) has already widely established itself in southern Europe and is spreading towards central parts of the continent. Public health authorities and policymakers need to be informed about where and when a chikungunya transmission is likely to take place. Here, we adapted a previously published global ecological niche model (ENM) by including only non-tropical chikungunya occurrence records and selecting bioclimatic variables that can reflect the temperate and sub-tropical conditions in Europe with greater accuracy. Additionally, we applied an epidemiological model to capture the temporal outbreak risk of chikungunya in six selected European cities. Overall, the non-tropical ENM captures all the previous outbreaks in Europe, whereas the global ENM had underestimated the risk. Highly suitable areas are more widespread than previously assumed. They are found in coastal areas of the Mediterranean Sea, in the western part of the Iberian Peninsula, and in Atlantic coastal areas of France. Under a worst-case scenario, even large areas of western Germany and the Benelux states are considered potential areas of transmission. For the six selected European cities, June–September (the 22th–38th week) is the most vulnerable time period, with the maximum continuous duration of a possible transmission period lasting up to 93 days (Ravenna, Italy).
Collapse
Affiliation(s)
- Nils Benjamin Tjaden
- Department of Biogeography, University of Bayreuth, D-95447 Bayreuth, Germany; (N.B.T.); (Y.C.); (C.B.)
| | - Yanchao Cheng
- Department of Biogeography, University of Bayreuth, D-95447 Bayreuth, Germany; (N.B.T.); (Y.C.); (C.B.)
| | - Carl Beierkuhnlein
- Department of Biogeography, University of Bayreuth, D-95447 Bayreuth, Germany; (N.B.T.); (Y.C.); (C.B.)
- Bayreuth Center of Ecology and Environmental Research BayCEER, University of Bayreuth, D-95447 Bayreuth, Germany
| | - Stephanie Margarete Thomas
- Department of Biogeography, University of Bayreuth, D-95447 Bayreuth, Germany; (N.B.T.); (Y.C.); (C.B.)
- Bayreuth Center of Ecology and Environmental Research BayCEER, University of Bayreuth, D-95447 Bayreuth, Germany
- Correspondence: ; Tel.: +49-921-55-2307
| |
Collapse
|
5
|
Osman S, Preet R. Dengue, chikungunya and Zika in GeoSentinel surveillance of international travellers: a literature review from 1995 to 2020. J Travel Med 2020; 27:6007546. [PMID: 33258476 DOI: 10.1093/jtm/taaa222] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 11/18/2020] [Accepted: 11/19/2020] [Indexed: 12/19/2022]
Abstract
INTRODUCTION GeoSentinel is a global surveillance network of travel medicine providers seeing ill-returned travellers. Much of our knowledge on health problems and infectious encountered by international travellers has evolved as a result of GeoSentinel surveillance, providing geographic and temporal trends in morbidity among travellers while contributing to improved pre-travel advice. We set out to synthesize epidemiological information, clinical manifestations and time trends for dengue, chikungunya and Zika in travellers as captured by GeoSentinel. METHODS We conducted a systematic literature search in PubMed on international travellers who presented with dengue, chikungunya or Zika virus infections to GeoSentinel sites around the world from 1995 until 2020. RESULTS Of 107 GeoSentinel publications, 42 articles were related to dengue, chikungunya and/or Zika. The final analyses and synthesis of and results presented here are based on the findings from 27 original articles covering the three arboviral diseases. CONCLUSIONS Dengue is the most frequent arboviral disease encountered in travellers presenting to GeoSentinel sites, with increasing trends over the past two decades. In Southeast Asia, annual proportionate morbidity increased from 50 dengue cases per 1000 ill returned travellers in non-epidemic years to an average of 159 cases per 1000 travellers during epidemic years. The highest number of travellers with chikungunya virus infections was reported during the chikungunya outbreak in the Americas and the Caribbean in the years 2013-16. Zika was first reported by GeoSentinel already in 2012, but notifications peaked in the years 2016-17 reflecting the public health emergency in the Americas at the time.
Collapse
Affiliation(s)
- S Osman
- Department of Epidemiology and Global Health, Faculty of Medicine, Umeå University, Umeå, 90185, Sweden
| | - R Preet
- Department of Epidemiology and Global Health, Faculty of Medicine, Umeå University, Umeå, 90185, Sweden
| |
Collapse
|
6
|
Ozer T, Geiss BJ, Henry CS. Review-Chemical and Biological Sensors for Viral Detection. JOURNAL OF THE ELECTROCHEMICAL SOCIETY 2020; 167:037523. [PMID: 32287357 PMCID: PMC7106559 DOI: 10.1149/2.0232003jes] [Citation(s) in RCA: 78] [Impact Index Per Article: 19.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Revised: 11/25/2019] [Indexed: 05/19/2023]
Abstract
Infectious diseases commonly occur in contaminated water, food, and bodily fluids and spread rapidly, resulting in death of humans and animals worldwide. Among infectious agents, viruses pose a serious threat to public health and global economy because they are often difficult to detect and their infections are hard to treat. Since it is crucial to develop rapid, accurate, cost-effective, and in-situ methods for early detection viruses, a variety of sensors have been reported so far. This review provides an overview of the recent developments in electrochemical sensors and biosensors for detecting viruses and use of these sensors on environmental, clinical and food monitoring. Electrochemical biosensors for determining viruses are divided into four main groups including nucleic acid-based, antibody-based, aptamer-based and antigen-based electrochemical biosensors. Finally, the drawbacks and advantages of each type of sensors are identified and discussed.
Collapse
Affiliation(s)
- Tugba Ozer
- Department of Chemistry, Colorado State University, USA
- Yildiz Technical University, Faculty of Chemistry-Metallurgy, Department of Bioengineering, Istanbul, Turkey
| | - Brian J Geiss
- Department of Microbiology, Immunology & Pathology, Colorado State University, USA
- School of Biomedical Engineering, Colorado State University, USA
| | - Charles S Henry
- Department of Chemistry, Colorado State University, USA
- School of Biomedical Engineering, Colorado State University, USA
| |
Collapse
|
7
|
Monier EB, Araújo DV, Oliveira AEF, Baesse DCL, Pinho JRO, Brasil GVS, Mesquita MN. Student Evaluation of Distance Learning for Health Care Professionals. Telemed J E Health 2018; 25:485-491. [PMID: 30020855 DOI: 10.1089/tmj.2018.0065] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Background: To meet the population's health needs, it is necessary to have health professionals highly trained and updated with the latest skills. The Brazilian government, through the Open University of Brazilian National Health System (UNA-SUS), offers continuing education with free access, in distance learning (DL) modality. Objective: This study aimed to analyze students' perceptions regarding didactic and pedagogical aspects related to the content and activities, educational resources, and tutoring in a module offered by UNA-SUS/Federal University of Maranhão (UFMA). Methods: The authors analyzed a sample of 319 students, enrolled in four postgraduate classes, who had completed the communicable diseases module, from 2013 to 2014, and responded to evaluation questions through the Integrated Management System (SIGU) questionnaire, an auxiliary system for processing and interpreting assessments of DL modules offered by UNA-SUS/UFMA. For statistical analysis, evaluation variables were dichotomized into either a positive outcome ("great" and "good") or a negative outcome ("bad" and "insufficient"). Data were analyzed using Statistical Package for the Social Sciences (SPSS®; version 18); the significance level was set at 5% (p < 0.05). Results: The authors observed that 99% of the students evaluated the module positively. Regarding the evaluation of the content and activities, 53% (169), 43.6% (139), and 3.4% (11) of students evaluated the item unit workload as great, good, and bad, respectively. The highest rated item was tutor performance, rated as great by 229 (71.8%) students. Conclusions: The results contributed to the improvement of DL courses offered by UNA-SUS/UFMA from the perspectives of controlling dropout rates and the development of public health services offered in Brazil.
Collapse
Affiliation(s)
- Elza Bernardes Monier
- 1 Department of Dentistry I, Federal University of Maranhão, Sao Luis, Brazil.,2 Postgraduate Program in Medical Sciences, Rio de Janeiro State University, Rio de Janeiro, Brazil
| | - Denizar Vianna Araújo
- 3 Department of Clinical Medicine, Rio de Janeiro State University, Rio de Janeiro, Brazil
| | | | - Deborah C L Baesse
- 4 Department of Pedagogy, Federal University of Maranhão, Sao Luis, Brazil
| | | | - Gabrielle V S Brasil
- 6 Open University of Brazilian National Health System, Federal University of Maranhão, Sao Luis, Brazil
| | - Mizraim N Mesquita
- 6 Open University of Brazilian National Health System, Federal University of Maranhão, Sao Luis, Brazil
| |
Collapse
|
8
|
Dorléans F, Hoen B, Najioullah F, Herrmann-Storck C, Schepers KM, Abel S, Lamaury I, Fagour L, Césaire R, Guyomard S, Troudard R, Adélaïde Y, Romagne MJ, Davidas M, Rochais S, Boa S, de Saint-Alary F, Preira A, Saint-Martin P, Vaidie A, Melin M, Daudens-Vaysse E, Rosine J, Blateau A, Carvalho L, Septfons A, Paty MC, Leduc G, Cassadou S, Ledrans M, Cabié A. Outbreak of Chikungunya in the French Caribbean Islands of Martinique and Guadeloupe: Findings from a Hospital-Based Surveillance System (2013-2015). Am J Trop Med Hyg 2018; 98:1819-1825. [PMID: 29692295 PMCID: PMC6086161 DOI: 10.4269/ajtmh.16-0719] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Accepted: 07/21/2017] [Indexed: 11/26/2022] Open
Abstract
Chikungunya virus (CHIKV) emerged in the Caribbean island of Saint-Martin in December 2013. We implemented a hospital-based surveillance system to detect and describe CHIKV cases including severe forms of the infection and deaths in the islands of Martinique and Guadeloupe. A case was defined as a patient with a CHIKV laboratory confirmation cared for in a public hospital for chikungunya for at least 24 hours, and a severe CHIKV case was defined as a CHIKV case presenting one or more organ failures. Sociodemographic, clinical, and laboratory data were collected and cases classified into severe or nonsevere based on medical records. From December 2013 to January 2015, a total of 1,836 hospitalized cases were identified. Rate of hospital admissions for CHIKV infection was 60 per 10,000 suspected clinical CHIKV cases and severity accounted for 12 per 10,000. A total of 74 deaths related to CHIKV infection occurred. Infants and elderly people were more frequently hospitalized compared with others and severity was more frequently reported in elderly subjects and subjects with underlying health condition. Fifteen neonatal infections consecutive to mother-to-child transmission were diagnosed, seven of which were severe. The most vulnerable groups of the population, such as the elderly, infants, individuals with comorbidities, and pregnant women, should remain the main targets of public health priorities.
Collapse
Affiliation(s)
- Frédérique Dorléans
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Bruno Hoen
- Université des Antilles, Faculté de Médecine Hyacinthe Bastaraud, Pointe-à-Pitre, France
- Infectious Diseases Department, University Hospital, Pointe-à-Pitre, Guadeloupe
- Centre Hospitalier Universitaire de Pointe-à-Pitre, Inserm CIC1424, Service de Maladies Infectieuses et Tropicales, Dermatologie, Médecine Interne, Pointe-à-Pitre, France
| | - Fatiha Najioullah
- Virology Laboratory, University Hospital, Fort-de-France, Martinique
| | | | | | - Sylvie Abel
- Infectious Diseases Department, University Hospital, Fort-de-France, Martinique
| | - Isabelle Lamaury
- Infectious Diseases Department, University Hospital, Pointe-à-Pitre, Guadeloupe
| | - Laurence Fagour
- Virology Laboratory, University Hospital, Fort-de-France, Martinique
| | - Raymond Césaire
- Virology Laboratory, University Hospital, Fort-de-France, Martinique
| | | | - Ruth Troudard
- Infectious Diseases Department, University Hospital, Fort-de-France, Martinique
| | - Yvette Adélaïde
- Regional Health Authority of Martinique, Fort-de-France, Martinique
| | | | - Magguy Davidas
- Regional Health Authority of Martinique, Fort-de-France, Martinique
| | - Séverine Rochais
- Regional Health Authority of Martinique, Fort-de-France, Martinique
| | - Sylvie Boa
- Regional Health Authority of Guadeloupe, Gourbeyre, Guadeloupe
| | | | - Annabel Preira
- Regional Health Authority of Guadeloupe, Gourbeyre, Guadeloupe
| | - Patrick Saint-Martin
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
- Infectious Diseases Department, University Hospital, Fort-de-France, Martinique
- Université des Antilles, Faculté de Médecine Hyacinthe Bastaraud, Pointe-à-Pitre, France
- Virology Laboratory, University Hospital, Fort-de-France, Martinique
- Virology Laboratory, University Hospital, Pointe-à-Pitre, Guadeloupe
- Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe
- Regional Health Authority of Martinique, Fort-de-France, Martinique
- Regional Health Authority of Guadeloupe, Gourbeyre, Guadeloupe
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France
- Infectious Diseases Department, University Hospital, Pointe-à-Pitre, Guadeloupe
- Université des Antilles, Faculté de Médecine Hyacinthe Bastaraud, Fort-de-France, France
- Centre Hospitalier Universitaire de Martinique, INSERM CIC1424, Service de Maladies Infectieuses et Tropicales, Médecine Polyvalente, Fort-de-France, France
- Centre Hospitalier Universitaire de Pointe-à-Pitre, Inserm CIC1424, Service de Maladies Infectieuses et Tropicales, Dermatologie, Médecine Interne, Pointe-à-Pitre, France
| | - Amandine Vaidie
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Mathilde Melin
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Elise Daudens-Vaysse
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Jacques Rosine
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Alain Blateau
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Luisiane Carvalho
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Alexandra Septfons
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France
| | - Marie-Claire Paty
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France
| | - Ghislain Leduc
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Sylvie Cassadou
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - Martine Ledrans
- Santé Publique France, French National Public Health Agency, Regional Unit (Cire), Antilles-Guyane, Saint-Maurice, France
| | - André Cabié
- Université des Antilles, Faculté de Médecine Hyacinthe Bastaraud, Fort-de-France, France
- Centre Hospitalier Universitaire de Martinique, INSERM CIC1424, Service de Maladies Infectieuses et Tropicales, Médecine Polyvalente, Fort-de-France, France
| |
Collapse
|
9
|
Seroprevalence of Chikungunya virus in blood donors from Northern and Southeastern Brazil. Hematol Transfus Cell Ther 2018; 40:358-362. [PMID: 30370414 PMCID: PMC6200683 DOI: 10.1016/j.htct.2018.04.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2017] [Accepted: 04/05/2018] [Indexed: 11/21/2022] Open
Abstract
Background Chikungunya virus, an arbovirus that belongs to the Alphavirus genus of the Togaviridae family, causes a febrile illness accompanied by rash and arthralgia. It is estimated that during outbreaks, the prevalence of Chikungunya virus RNA in viremic blood donations varies between 0.4 and 2.1%; therefore, this virus may be transmitted by transfusion. In Brazil, Chikungunya virus has been claimed to cause extensive outbreaks, however, the seroprevalence of anti-Chikungunya virus IgG among Brazilian blood donors is unknown. Methods Eight hundred and ninety-seven blood samples were collected from volunteer blood donors in two distant localities long after the Chikungunya virus first appeared in Brazil. In 2015, 442 samples were collected from the Hemotherapy Service of Macapá, Amapá in the northern Brazilian Amazon. To evaluate the dissemination course of the virus in Brazil, in 2016, 455 blood samples were collected from the southeastern region (Blood Center of Ribeirão Preto, Ribeirão Preto, São Paulo). All samples were tested for the presence of anti-Chikungunya virus IgG and viral RNA. Results One sample (0.2%) obtained from the Hemotherapy Center of Macapá tested positive for anti-Chikungunya virus IgG and no sample from the Blood Center of Ribeirão Preto was seroreactive to anti-Chikungunya virus IgG. All blood donations were Chikungunya virus RNA negative. Conclusions This study, performed during 2015–2016, indicates that the transfusion risk of Chikungunya virus in this period was low. However, due to the constant advance of this virus in Brazil, further studies during outbreaks are needed to evaluate the presence of Chikungunya virus RNA in blood donations and the respective transfusion-transmission risk.
Collapse
|
10
|
Yang S, Fink D, Hulse A, Pratt RD. Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus. Vaccine 2017; 35:4851-4858. [PMID: 28760614 DOI: 10.1016/j.vaccine.2017.07.065] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2017] [Revised: 06/21/2017] [Accepted: 07/19/2017] [Indexed: 12/01/2022]
Abstract
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus. Chikungunya disease (CHIK) in humans is characterized by sudden onset of high fever, cutaneous rash, myalgia and debilitating polyarthralgia. Until recently the virus was considered endemic to only Africa and Asia, but since 2004 CHIK has spread to previously non-endemic regions, including Europe and the Americas, thereby emerging as a global health threat. Although a variety of CHIKV vaccine candidates have been tested in animals, and a few have advanced to human clinical trials, no licensed vaccine is currently available for prevention of disease. In this article, we review recent efforts in CHIKV vaccine development and discuss regulatory considerations for CHIKV vaccine licensure under U.S. FDA regulations. Several licensure pathways are available, and the most appropriate licensure pathway for a CHIK vaccine will depend on the type of evidence that can be generated to demonstrate the vaccine's effectiveness. If "traditional approval" following demonstration of direct benefit in adequate and well-controlled clinical disease endpoint studies is not possible, the Accelerated Approval and Animal Rule pathways are potential alternatives. In terms of vaccine safety, the potential for vaccine associated arthralgia and antibody-dependent enhancement of infectivity and disease severity are important issues that should be addressed in both pre-clinical and clinical studies. CHIK vaccine developers are encouraged to communicate with the FDA during all stages of vaccine development.
Collapse
Affiliation(s)
- Sixun Yang
- Division of Vaccines and Related Product Applications, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.
| | - Doran Fink
- Division of Vaccines and Related Product Applications, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States
| | - Andrea Hulse
- Division of Vaccines and Related Product Applications, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States
| | - R Douglas Pratt
- Division of Vaccines and Related Product Applications, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States
| |
Collapse
|
11
|
Vlieg WL, Fanoy EB, van Asten L, Liu X, Yang J, Pilot E, Bijkerk P, van der Hoek W, Krafft T, van der Sande MA, Liu QY. Comparing national infectious disease surveillance systems: China and the Netherlands. BMC Public Health 2017; 17:415. [PMID: 28482830 PMCID: PMC5423001 DOI: 10.1186/s12889-017-4319-3] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2016] [Accepted: 04/26/2017] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Risk assessment and early warning (RAEW) are essential components of any infectious disease surveillance system. In light of the International Health Regulations (IHR)(2005), this study compares the organisation of RAEW in China and the Netherlands. The respective approaches towards surveillance of arboviral disease and unexplained pneumonia were analysed to gain a better understanding of the RAEW mode of operation. This study may be used to explore options for further strengthening of global collaboration and timely detection and surveillance of infectious disease outbreaks. METHODS A qualitative study design was used, combining data retrieved from the literature and from semi-structured interviews with Chinese (5 national-level and 6 provincial-level) and Dutch (5 national-level) experts. RESULTS The results show that some differences exist such as in the use of automated electronic components of the early warning system in China ('CIDARS'), compared to a more limited automated component in the Netherlands ('barometer'). Moreover, RAEW units in the Netherlands focus exclusively on infectious diseases, while China has a broader 'all hazard' approach (including for example chemical incidents). In the Netherlands, veterinary specialists take part at the RAEW meetings, to enable a structured exchange/assessment of zoonotic signals. CONCLUSION Despite these differences, the main conclusion is that for the two infections studied, the early warning system in China and the Netherlands are remarkably similar considering their large differences in infectious disease history, population size and geographical setting. Our main recommendations are continued emphasis on international corporation that requires insight into national infectious disease surveillance systems, the usage of a One Health approach in infectious disease surveillance, and further exploration/strengthening of a combined syndromic and laboratory surveillance system.
Collapse
Affiliation(s)
- Willemijn L. Vlieg
- Department of Health, Ethics & Society, CAPHRI School of Public Health and Primary Care, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
- Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - Ewout B. Fanoy
- Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
- Public Health Service, region Utrecht, Zeist, The Netherlands
| | - Liselotte van Asten
- Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - Xiaobo Liu
- State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, 102206 China
| | - Jun Yang
- State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, 102206 China
| | - Eva Pilot
- Department of Health, Ethics & Society, CAPHRI School of Public Health and Primary Care, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
| | - Paul Bijkerk
- Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - Wim van der Hoek
- Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
| | - Thomas Krafft
- Department of Health, Ethics & Society, CAPHRI School of Public Health and Primary Care, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
| | - Marianne A. van der Sande
- Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
- Julius Centre for Primary Care and Public Health, University Medical Centre, Utrecht, The Netherlands
| | - Qi-Yong Liu
- State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, 102206 China
| |
Collapse
|
12
|
Leal Neto O, Dimech GS, Libel M, de Souza WV, Cesse E, Smolinski M, Oliveira W, Albuquerque J. Saúde na Copa: The World's First Application of Participatory Surveillance for a Mass Gathering at FIFA World Cup 2014, Brazil. JMIR Public Health Surveill 2017; 3:e26. [PMID: 28473308 PMCID: PMC5438444 DOI: 10.2196/publichealth.7313] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2017] [Revised: 02/23/2017] [Accepted: 03/20/2017] [Indexed: 11/29/2022] Open
Abstract
Background The 2005 International Health Regulations (IHRs) established parameters for event assessments and notifications that may constitute public health emergencies of international concern. These requirements and parameters opened up space for the use of nonofficial mechanisms (such as websites, blogs, and social networks) and technological improvements of communication that can streamline the detection, monitoring, and response to health problems, and thus reduce damage caused by these problems. Specifically, the revised IHR created space for participatory surveillance to function, in addition to the traditional surveillance mechanisms of detection, monitoring, and response. Participatory surveillance is based on crowdsourcing methods that collect information from society and then return the collective knowledge gained from that information back to society. The spread of digital social networks and wiki-style knowledge platforms has created a very favorable environment for this model of production and social control of information. Objective The aim of this study was to describe the use of a participatory surveillance app, Healthy Cup, for the early detection of acute disease outbreaks during the Fédération Internationale de Football Association (FIFA) World Cup 2014. Our focus was on three specific syndromes (respiratory, diarrheal, and rash) related to six diseases that were considered important in a mass gathering context (influenza, measles, rubella, cholera, acute diarrhea, and dengue fever). Methods From May 12 to July 13, 2014, users from anywhere in the world were able to download the Healthy Cup app and record their health condition, reporting whether they were good, very good, ill, or very ill. For users that reported being ill or very ill, a screen with a list of 10 symptoms was displayed. Participatory surveillance allows for the real-time identification of aggregates of symptoms that indicate possible cases of infectious diseases. Results From May 12 through July 13, 2014, there were 9434 downloads of the Healthy Cup app and 7155 (75.84%) registered users. Among the registered users, 4706 (4706/7155, 65.77%) were active users who posted a total of 47,879 times during the study period. The maximum number of users that signed up in one day occurred on May 30, 2014, the day that the app was officially launched by the Minister of Health during a press conference. During this event, the Minister of Health announced the special government program Health in the World Cup on national television media. On that date, 3633 logins were recorded, which accounted for more than half of all sign-ups across the entire duration of the study (50.78%, 3633/7155). Conclusions Participatory surveillance through community engagement is an innovative way to conduct epidemiological surveillance. Compared to traditional epidemiological surveillance, advantages include lower costs of data acquisition, timeliness of information collected and shared, platform scalability, and capacity for integration between the population being served and public health services.
Collapse
Affiliation(s)
- Onicio Leal Neto
- EpitrackRecifeBrazil.,SingularityU Recife ChapterRecifeBrazil.,Aggeu Magalhães Research CenterDepartament of Health CollectiveRecifeBrazil
| | | | - Marlo Libel
- Skoll Global Threats FundPandemics TeamSan Francisco, CAUnited States
| | | | - Eduarda Cesse
- Aggeu Magalhães Research CenterDepartament of Public HealthRecifeBrazil
| | - Mark Smolinski
- Skoll Global Threats FundPandemics TeamSan Francisco, CAUnited States
| | - Wanderson Oliveira
- Brazil's Ministry of HealthGeneral Coordination of Public Health Emergencies ResponseBrasiliaBrazil
| | - Jones Albuquerque
- EpitrackRecifeBrazil.,Federal Rural University of PernambucoInformatics DepartamentRecifeBrazil
| |
Collapse
|
13
|
Handler MZ, Handler NS, Stephany MP, Handler GA, Schwartz RA. Chikungunya fever: an emerging viral infection threatening North America and Europe. Int J Dermatol 2016; 56:e19-e25. [DOI: 10.1111/ijd.13439] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/27/2015] [Accepted: 07/09/2016] [Indexed: 01/28/2023]
Affiliation(s)
- Marc Z. Handler
- Dermatology and Pathology; Rutgers New Jersey Medical School and Rutgers School of Public Affairs and Administration; Newark NJ USA
| | | | | | - Glenn A. Handler
- Dermatology and Pathology; Rutgers New Jersey Medical School and Rutgers School of Public Affairs and Administration; Newark NJ USA
| | - Robert A. Schwartz
- Dermatology and Pathology; Rutgers New Jersey Medical School and Rutgers School of Public Affairs and Administration; Newark NJ USA
| |
Collapse
|
14
|
Paniz-Mondolfi AE, Rodriguez-Morales AJ, Blohm G, Marquez M, Villamil-Gomez WE. ChikDenMaZika Syndrome: the challenge of diagnosing arboviral infections in the midst of concurrent epidemics. Ann Clin Microbiol Antimicrob 2016; 15:42. [PMID: 27449770 PMCID: PMC4957883 DOI: 10.1186/s12941-016-0157-x] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2016] [Accepted: 07/08/2016] [Indexed: 02/03/2023] Open
Affiliation(s)
- Alberto E. Paniz-Mondolfi
- />Department of Pathology and Laboratory Medicine, Hospital Internacional, Barquisimeto, Venezuela
- />Laboratory of Biochemistry, Instituto de Biomedicina/IVSS, Caracas, Venezuela
| | - Alfonso J. Rodriguez-Morales
- />Colombian Collaborative Network on Zika (RECOLZIKA), Pereira, Risaralda Colombia
- />Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Risaralda Colombia
- />Organización Latinoamericana Para el Fomento de la Investigación en Salud (OLFIS), Bucaramanga, Santander Colombia
- />Committee on Zoonoses and Haemorrhagic Fevers, Asociación Colombiana de Infectología (ACIN), Bogotá, DC Colombia
| | - Gabriela Blohm
- />Department of Biology, University of Florida, Gainesville, FL USA
| | - Marilianna Marquez
- />Department of Pathology and Laboratory Medicine, Hospital Internacional, Barquisimeto, Venezuela
| | - Wilmer E. Villamil-Gomez
- />Colombian Collaborative Network on Zika (RECOLZIKA), Pereira, Risaralda Colombia
- />Committee on Zoonoses and Haemorrhagic Fevers, Asociación Colombiana de Infectología (ACIN), Bogotá, DC Colombia
- />Infectious Diseases and Infection Control Research Group, Hospital Universitario de Sincelejo, Sincelejo, Sucre Colombia
- />Programa del Doctorado de Medicina Tropical, Universidad del Atlántico, Barranquilla, Atlántico, Colombia
| |
Collapse
|
15
|
Biron A, Cazorla C, Amar J, Pfannstiel A, Dupont-Rouzeyrol M, Goarant C. Zika virus infection as an unexpected finding in a Leptospirosis patient. JMM Case Rep 2016; 3:e005033. [PMID: 28348757 PMCID: PMC5330225 DOI: 10.1099/jmmcr.0.005033] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2016] [Accepted: 03/23/2016] [Indexed: 11/22/2022] Open
Abstract
Introduction: Areas where leptospirosis and arboviruses are endemic largely overlap in the tropics. However, the number of arbovirus infections is usually much higher. The initial clinical presentation can be highly confusing; therefore, laboratory confirmation is key to an accurate diagnosis. Case Presentation: A 19–year–old man presented to a peripheral health centre with an acute febrile illness. Dengue was initially suspected, but the patient deteriorated to a shock syndrome. Leptospirosis as well as a co-infection with Zika virus were both confirmed in the laboratory, the latter being clinically masked in this dual infection. Conclusion: This case highlights the importance of not only considering the differential diagnosis of acute febrile syndromes, but also to consider the possibility of dual infections in the context of global spread of arboviruses. The specific context of travellers returning from endemic areas and pregnant women is also highlighted and discussed.
Collapse
Affiliation(s)
- Antoine Biron
- Institut Pasteur de Nouvelle-Caledonie, Medical Virology Laboratory , Nouméa , New Caledonia
| | - Cécile Cazorla
- Centre Hospitalier Territorial de Nouvelle-Caledonie, Infectious Disease Department , Nouméa , New Caledonia
| | - Julien Amar
- Centre Hospitalier Territorial de Nouvelle-Caledonie, Intensive Care Unit , Nouméa , New Caledonia
| | - Anne Pfannstiel
- Gouvernement de la Nouvelle-Caledonie, Direction des Affaires Sanitaires et Sociales , Nouméa , New Caledonia
| | - Myrielle Dupont-Rouzeyrol
- Institut Pasteur de Nouvelle-Caledonie, Arbovirus Research and Expertise Unit , Nouméa , New Caledonia
| | - Cyrille Goarant
- Institut Pasteur de Nouvelle-Caledonie, Leptospirosis Research and Expertise Unit , Nouméa , New Caledonia
| |
Collapse
|
16
|
Tsiodras S, Pervanidou D, Papadopoulou E, Kavatha D, Baka A, Koliopoulos G, Badieritakis E, Michaelakis A, Gavana E, Patsoula E, Tsimpos I, Gioksari T, Kyriazopoulou E, Vakali A, Pavli A, Maltezou HC, Georgakopoulou T, Hadjichristodoulou C, Kremastinou J, Papa A. Imported Chikungunya fever case in Greece in June 2014 and public health response. Pathog Glob Health 2016; 110:68-73. [PMID: 27159571 PMCID: PMC4894267 DOI: 10.1080/20477724.2016.1176311] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
We report about the first imported case of Chikungunya fever in Greece in a Greek traveler returning from the Dominican Republic and the associated public health response. We investigated the case and performed focused epidemiological and entomological investigation in all areas the patient visited during the infectious period, to identify the targeted interventions needed. Entomological investigation revealed the occurrence of the competent vector Aedes albopictus (Diptera: Culicidae) in the environment surrounding the hospital where the patient was admitted and in her workplace. All captured mosquitoes tested negative for Chikungunya virus. We further conducted clinical and laboratory examination of the patient's co-travelers, gave advice on appropriate personal preventive measures against mosquito bites to the patient and co-travelers and on vector control, and raised awareness among health professionals throughout Greece. The risk of introduction and local transmission of Chikungunya and other arboviruses in Greece and other European countries is present, as the competent vector exists in many parts of Europe. Public health professionals, travel medicine specialists and clinicians should maintain awareness regarding this possibility of importation of arbovirus cases in order to provide the appropriate advice, seek the prompt diagnosis, and implement appropriate interventions. Mobilization of various stakeholders will lead to enhanced epidemiological and entomological surveillance that will allow for improved risk assessment in each area.
Collapse
Affiliation(s)
- Sotirios Tsiodras
- a 4th Department of Internal Medicine , Attikon University Hospital, Athens University Medical School , Athens , Greece
- b Hellenic Center for Disease Control and Prevention , Athens , Greece
| | - Danai Pervanidou
- b Hellenic Center for Disease Control and Prevention , Athens , Greece
| | - Elpida Papadopoulou
- c A' Department of Microbiology, Medical School, National Reference Centre for Arboviruses and Hemorrhagic Fever Viruses , Aristotle University of Thessaloniki , Thessaloniki , Greece
| | - Dimitra Kavatha
- a 4th Department of Internal Medicine , Attikon University Hospital, Athens University Medical School , Athens , Greece
| | - Agoritsa Baka
- b Hellenic Center for Disease Control and Prevention , Athens , Greece
| | | | | | | | - Elpida Gavana
- c A' Department of Microbiology, Medical School, National Reference Centre for Arboviruses and Hemorrhagic Fever Viruses , Aristotle University of Thessaloniki , Thessaloniki , Greece
| | - Eleni Patsoula
- e Department of Parasitology, Entomology and Tropical Diseases , National School of Public Health , Athens , Greece
| | - Ioannis Tsimpos
- a 4th Department of Internal Medicine , Attikon University Hospital, Athens University Medical School , Athens , Greece
| | - Thalia Gioksari
- a 4th Department of Internal Medicine , Attikon University Hospital, Athens University Medical School , Athens , Greece
| | - Evdoxia Kyriazopoulou
- a 4th Department of Internal Medicine , Attikon University Hospital, Athens University Medical School , Athens , Greece
| | - Annita Vakali
- b Hellenic Center for Disease Control and Prevention , Athens , Greece
| | - Androula Pavli
- b Hellenic Center for Disease Control and Prevention , Athens , Greece
| | - Helena C Maltezou
- b Hellenic Center for Disease Control and Prevention , Athens , Greece
| | | | - Christos Hadjichristodoulou
- b Hellenic Center for Disease Control and Prevention , Athens , Greece
- f Department of Hygiene and Epidemiology , University of Thessaly , Larisa , Greece
| | - Jenny Kremastinou
- b Hellenic Center for Disease Control and Prevention , Athens , Greece
| | - Anna Papa
- c A' Department of Microbiology, Medical School, National Reference Centre for Arboviruses and Hemorrhagic Fever Viruses , Aristotle University of Thessaloniki , Thessaloniki , Greece
| |
Collapse
|
17
|
Increased number of cases of Chikungunya virus (CHIKV) infection imported from the Caribbean and Central America to northern Italy, 2014. Epidemiol Infect 2016; 144:1912-6. [PMID: 26751121 DOI: 10.1017/s0950268815002940] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
This report describes an increased number of cases of Chikungunya virus (CHIKV) infection imported in northern Italy (Emilia-Romagna region) during the period May-September 2014, indicating that the recent spread of CHIKV and its establishment in the Caribbean and in central America, resulted in a high number of imported cases in Europe, thus representing a threat to public health. From May to September 2014, 14 imported cases of CHIKV infection were diagnosed; the patients were returning to Italy from Dominican Republic (n = 6), Haiti (n = 3), Guadeloupe (n = 2), Martinique (n = 1), Puerto Rico (n = 1) and Venezuela (n = 1). Phylogenetic analysis performed on the envelope protein (E1) gene sequences, obtained from plasma samples from two patients, indicated that the virus strain belongs to the Caribbean clade of the Asian genotype currently circulating in the Caribbean and Americas. The rise in the number of imported cases of CHIKV infection should increase healthcare professionals' awareness of the epidemiological situation and clinical presentation of CHIKV infection in order to enhance surveillance and early diagnosis in the forthcoming season of vector activity in Europe and North America.
Collapse
|
18
|
Gay N, Rousset D, Huc P, Matheus S, Ledrans M, Rosine J, Cassadou S, Noël H. Seroprevalence of Asian Lineage Chikungunya Virus Infection on Saint Martin Island, 7 Months After the 2013 Emergence. Am J Trop Med Hyg 2015; 94:393-396. [PMID: 26643536 PMCID: PMC4751936 DOI: 10.4269/ajtmh.15-0308] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2015] [Accepted: 10/16/2015] [Indexed: 12/04/2022] Open
Abstract
At the end of 2013, chikungunya virus (CHIKV) emerged in Saint Martin Island, Caribbean. The Asian lineage was identified. Seven months after this introduction, the seroprevalence was 16.9% in the population of Saint Martin and 39.0% of infections remained asymptomatic. This moderate attack rate and the apparent limited size of the outbreak in Saint Martin could be explained by control measures involved to lower the exposure of the inhabitants. Other drivers such as climatic factors and population genetic factors should be explored. The substantial rate of asymptomatic infections recorded points to a potential source of infection that can both spread in new geographic areas and maintain an inconspicuous endemic circulation in the Americas.
Collapse
Affiliation(s)
- Noellie Gay
- *Address correspondence to Noellie Gay, Cire Antilles-Guyane, Centre d'Affaires Agora, ZAC de l'Etang Z'Abricot, Pointe des Grives - BP 658, 97261 Fort-de-France cedex. E-mail:
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Dalla Gasperina D, Balsamo ML, Garavaglia SD, Rovida F, Baldanti F, Grossi PA. Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic. Transpl Infect Dis 2015; 17:876-9. [PMID: 26771689 DOI: 10.1111/tid.12453] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2015] [Revised: 06/18/2015] [Accepted: 08/13/2015] [Indexed: 01/04/2023]
Abstract
Since December 2013, chikungunya virus (CHIKV) spread in many countries of the Western Hemisphere, and during the last year some cases of infected European travelers, coming back from the Caribbean, have been reported. The risk of acquiring severe travel-related illness is higher in immunocompromised subjects, such as patients with human immunodeficiency virus (HIV) infection or solid organ transplant recipients. We reported the first case, to our knowledge, of CHIKV infection in an HIV-infected kidney transplant recipient.
Collapse
Affiliation(s)
- D Dalla Gasperina
- Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
| | - M L Balsamo
- Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
| | - S D Garavaglia
- Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
| | - F Rovida
- Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | - F Baldanti
- Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | - P A Grossi
- Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
| |
Collapse
|
20
|
Jourdain F, Roiz D, Perrin Y, Grucker K, Simard F, Paupy C. [Entomological factors of arboviruses emergences]. Transfus Clin Biol 2015; 22:101-6. [PMID: 26141429 DOI: 10.1016/j.tracli.2015.06.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2015] [Indexed: 10/23/2022]
Abstract
Arboviruses - viruses transmitted by haematophagous arthropods - are responsible for febrile syndromes, which sometimes include haemorrhagic or neurological symptoms. Human activities have facilitated the emergence of these originally zoonotic viruses and the domestication and spread throughout the world of their major vectors. The last decade has seen significant changes in the epidemiology of arboviruses transmitted by mosquitoes of the genus Aedes, particularly in relation to the intercontinental spread of Aedes albopictus. Here, we address the epidemiological consequences of the invasion by this species into Central Africa and Europe in a context of viral globalization. The risk of transmission in these areas is influenced by virus-vector adaptation phenomena as well as environmental phenomena including climate. Faced with these new risks, it is essential to develop competences in entomological and virological surveillance, risk assessment and forecasting of epidemic risk in order to develop strategies for the prevention and control of epidemics.
Collapse
Affiliation(s)
- F Jourdain
- Centre national d'expertise sur les vecteurs, BP 64501, 34394 Montpellier cedex 5, France
| | - D Roiz
- MIVEGEC, UMR IRD 224-CNRS 5290-UM, centre IRD de Montpellier, BP 64501, 34394 Montpellier cedex 5, France
| | - Y Perrin
- Centre national d'expertise sur les vecteurs, BP 64501, 34394 Montpellier cedex 5, France
| | - K Grucker
- Centre national d'expertise sur les vecteurs, BP 64501, 34394 Montpellier cedex 5, France
| | - F Simard
- MIVEGEC, UMR IRD 224-CNRS 5290-UM, centre IRD de Montpellier, BP 64501, 34394 Montpellier cedex 5, France
| | - C Paupy
- MIVEGEC, UMR IRD 224-CNRS 5290-UM, centre IRD de Montpellier, BP 64501, 34394 Montpellier cedex 5, France.
| |
Collapse
|
21
|
Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease. J Virol 2015; 89:8063-76. [PMID: 26018160 DOI: 10.1128/jvi.00224-15] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2015] [Accepted: 05/19/2015] [Indexed: 12/16/2022] Open
Abstract
UNLABELLED Arthritogenic alphaviruses such as Ross River virus (RRV) and chikungunya virus (CHIKV) cause large-scale epidemics of severe musculoskeletal disease and have been progressively expanding their global distribution. Since its introduction in July 2014, CHIKV now circulates in the United States. The hallmark of alphavirus disease is crippling pain and inflammation of the joints, a similar immunopathology to rheumatoid arthritis. The use of glycans as novel therapeutics is an area of research that has increased in recent years. Here, we describe the promising therapeutic potential of the glycosaminoglycan (GAG)-like molecule pentosan polysulfate (PPS) to alleviate virus-induced arthritis. Mouse models of RRV and CHIKV disease were used to characterize the extent of cartilage damage in infection and investigate the potential of PPS to treat disease. This was assessed using histological analysis, real-time PCR, and fluorescence-activated cell sorting (FACS). Alphaviral infection resulted in cartilage destruction, the severity of which was alleviated by PPS therapy during RRV and CHIKV clinical disease. The reduction in cartilage damage corresponded with a significant reduction in immune infiltrates. Using multiplex bead arrays, PPS treatment was found to have significantly increased the anti-inflammatory cytokine interleukin-10 and reduced proinflammatory cytokines, typically correlated with disease severity. Furthermore, we reveal that the severe RRV-induced joint pathology, including thinning of articular cartilage and loss of proteoglycans in the cartilage matrix, was diminished with treatment. PPS is a promising new therapy for alphavirus-induced arthritis, acting to preserve the cartilage matrix, which is damaged during alphavirus infection. Overall, the data demonstrate the potential of glycotherapeutics as a new class of treatment for infectious arthritis. IMPORTANCE The hallmark of alphavirus disease is crippling pain and joint arthritis, which often has an extended duration. In the past year, CHIKV has expanded into the Americas, with approximately 1 million cases reported to date, whereas RRV continues to circulate in the South Pacific. Currently, there is no licensed specific treatment for alphavirus disease, and the increasing spread of infection highlights an urgent need for therapeutic intervention strategies. Pentosan polysulfate (PPS) is a glycan derivative that is orally bioavailable, has few toxic side effects, and is currently licensed under the name Elmiron for the treatment of cystitis in the United States. Our findings show that RRV infection damages the articular cartilage, including a loss of proteoglycans within the joint. Furthermore, treatment with PPS reduced the severity of both RRV- and CHIKV-induced musculoskeletal disease, including a reduction in inflammation and joint swelling, suggesting that PPS is a promising candidate for drug repurposing for the treatment of alphavirus-induced arthritis.
Collapse
|
22
|
Delisle E, Rousseau C, Broche B, Leparc-Goffart I, L’Ambert G, Cochet A, Prat C, Foulongne V, Ferré JB, Catelinois O, Flusin O, Tchernonog E, Moussion IE, Wiegandt A, Septfons A, Mendy A, Moyano MB, Laporte L, Maurel J, Jourdain F, Reynes J, Paty MC, Golliot F. Chikungunya outbreak in Montpellier, France, September to October 2014. Euro Surveill 2015; 20. [DOI: 10.2807/1560-7917.es2015.20.17.21108] [Citation(s) in RCA: 201] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
In October 2014, an outbreak of 12 autochthonous chikungunya cases, 11 confirmed and 1 probable, was detected in a district of Montpellier, a town in the south of France colonised by the vector Aedes albopictus since 2010. A case returning from Cameroon living in the affected district was identified as the primary case. The epidemiological investigations and the repeated vector control treatments performed in the area and around places frequented by cases helped to contain the outbreak. In 2014, the chikungunya and dengue surveillance system in mainland France was challenged by numerous imported cases due to the chikungunya epidemic ongoing in the Caribbean Islands. This first significant outbreak of chikungunya in Europe since the 2007 Italian epidemic, however, was due to an East Central South African (ECSA) strain, imported by a traveller returning from West Africa. Important lessons were learned from this episode, which reminds us that the threat of a chikungunya epidemic in southern Europe is real.
Collapse
Affiliation(s)
- E Delisle
- Regional office of the French Institute for Public Health Surveillance (Cire Languedoc-Roussillon), Montpellier, France
| | - C Rousseau
- Regional office of the French Institute for Public Health Surveillance (Cire Languedoc-Roussillon), Montpellier, France
| | - B Broche
- Regional Health Agency of Languedoc-Roussillon, Montpellier, France
| | - I Leparc-Goffart
- Institut de Recherche Biomédicale des Armées, National Reference Laboratory for arboviruses, Marseille, France
| | - G L’Ambert
- Entente Interdépartementale pour la Démoustication du littoral Méditerranéen (EID Méditerranée), Public mosquito control operator, Montpellier, France
| | - A Cochet
- Regional office of the French Institute for Public Health Surveillance (Cire Languedoc-Roussillon), Montpellier, France
| | - C Prat
- Institut de Recherche Biomédicale des Armées, National Reference Laboratory for arboviruses, Marseille, France
| | - V Foulongne
- Montpellier University Hospital, Montpellier, France
| | - J B Ferré
- Entente Interdépartementale pour la Démoustication du littoral Méditerranéen (EID Méditerranée), Public mosquito control operator, Montpellier, France
| | - O Catelinois
- Regional office of the French Institute for Public Health Surveillance (Cire Languedoc-Roussillon), Montpellier, France
| | - O Flusin
- Institut de Recherche Biomédicale des Armées, National Reference Laboratory for arboviruses, Marseille, France
| | - E Tchernonog
- Montpellier University Hospital, Montpellier, France
| | - I E Moussion
- Regional Health Agency of Languedoc-Roussillon, Montpellier, France
| | - A Wiegandt
- Regional Health Agency of Languedoc-Roussillon, Montpellier, France
| | - A Septfons
- French Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS), Saint-Maurice, France
| | - A Mendy
- Regional Health Agency of Languedoc-Roussillon, Montpellier, France
| | - M B Moyano
- Regional Health Agency of Languedoc-Roussillon, Montpellier, France
| | - L Laporte
- Regional Health Agency of Languedoc-Roussillon, Montpellier, France
| | - J Maurel
- Regional Health Agency of Languedoc-Roussillon, Montpellier, France
| | - F Jourdain
- National Centre of Expertise on Vectors, Montpelier, France
| | - J Reynes
- Montpellier University Hospital, Montpellier, France
| | - M C Paty
- National Centre of Expertise on Vectors, Montpelier, France
| | - F Golliot
- Regional office of the French Institute for Public Health Surveillance (Cire Languedoc-Roussillon), Montpellier, France
| |
Collapse
|
23
|
Emergence and Surveillance of Chikungunya. CURRENT TROPICAL MEDICINE REPORTS 2015. [DOI: 10.1007/s40475-015-0036-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|